Miramar Capital, LLC Amgen Inc Transaction History

Miramar Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $4.78 Million - $5.69 Million	-22,086 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $125,068 - $139,086	533 Added 2.47%	22,086 $5.29 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $7,912 - $9,709	-40 Reduced 0.19%	21,553 $5.25 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $106,428 - $141,152	-584 Reduced 2.63%	21,593 $4.38 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $12,298 - $15,808	-65 Reduced 0.29%	22,177 $4.92 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $41,786 - $50,068	240 Added 1.09%	22,242 $4.51 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $492,098 - $576,850	2,952 Added 15.5%	22,002 $3.83 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $12,299 - $13,863	-68 Reduced 0.36%	19,050 $3.62 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $3.41 Million - $3.98 Million	19,118 New	19,118 $3.6 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Miramar Capital, LLC with notifications on news.